Head-to-head · Cost-Efficiency Index
eMI Aesthetics vs Novi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
eMI Aesthetics
Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote.
Visit eMI AestheticsNovi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviThe verdict
eMI Aesthetics and Novi tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with eMI Aesthetics (ranked #99, a hair above #105) — Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote. But Novi is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs eMI Aesthetics.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | eMI Aesthetics | Novi |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $179/mo (compounded) | $99/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $269/mo (compounded) | $133/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,188 |
| Tirzepatide / yr (modeled) | $3,228 | $1,596 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #99 | #105 |
eMI Aesthetics
69/100Where the value is
- Available to eligible patients in all 50 U.S. states per the site's own GLP-1 program page
- Offers semaglutide in both injectable and oral form, plus tirzepatide, on one platform
- Full program cost is bundled — evaluation, medication, delivery, coaching, and follow-up with no separate fees itemized
The tradeoffs
- The advertised '$179/month' is the FLOOR of a $179-$249 range for the injection alone; oral semaglutide runs $209-$279 and tirzepatide $269-$339 — the actual price a patient pays isn't disclosed before intake
- No specific dispensing pharmacy is named
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.